Recombinant monoclonal antibody AK404R targets the outer 3 district KDR3 of human VEGFR2. This human antibody can suppress the inductive huve cell proliferation of VEGF institute external, and can be potentially used in the treatment of solid tumors.
Figure 1 Monoclonal phage ELISA to immobilized KDR3 (n = 3).
The illustrated scFvs exhibited high absorbance at OD450/650 in ELISA assay, indicating preferential phages with high affinity were successfully enriched. The experiment was repeated three times.
Zhang, J., Li, H., Wang, X., Qi, H., Miao, X., Zhang, T., ... & Wang, M. (2012). Phage‐derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF. Biotechnology progress, 28(4), 981-989.
Figure 2 Inhibition on VEGF stimulated proliferation of HUVECs.
The proliferative ability of HUVECs decreased gradually with the incubation of AK404R from 0.75 nM to 7.5 nM. The calculated concentration for 50% cell growth inhibition was 5 nM.
Zhang, J., Li, H., Wang, X., Qi, H., Miao, X., Zhang, T., ... & Wang, M. (2012). Phage‐derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF. Biotechnology progress, 28(4), 981-989.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
IAB-B066(A) | Recombinant Anti-human KDR Intrabody [(D-Arg)9] | FC, IF, FuncS | scFv-(D-Arg)9 |
IAB-B066(G) | Recombinant Anti-human KDR Intrabody [+36 GFP] | CO-IP, FuncS | scFv-(+36GFP) |
IAB-B066(T) | Recombinant Anti-human KDR Intrabody [Tat] | IF, ELISA, FuncS | scFv-Tat |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-202 | Humanized Anti-KDR Recombinant Antibody (clone Alacizumab); di - Fab' Fragment | IF, IP, Neut, FuncS, ELISA, FC, ICC | Humanized (from mouse) di - Fab' |
TAB-411CQ | Anti-Human KDR Recombinant Antibody (HLX06) | ELISA | Humanized antibody |
TAB-411CQ-S(P) | Anti-Human KDR Recombinant Antibody scFv Fragment (HLX06) | ELISA | Humanized antibody |
TAB-411CQ-F(E) | Anti-Human KDR Recombinant Antibody Fab Fragment (HLX06) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G047E | Anti-KDR immunotoxin (IgG1)-PE | Cytotoxicity assay, Function study |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBC-204 | Mouse Anti-KDR Recombinant Antibody (clone mAb6.64); scFv Fragment | Neut, Block | Mouse scFv |
HPAB-0097-YC-S(P) | Rabbit Anti-KDR Recombinant Antibody; scFv Fragment (HPAB-0097-YC-S(P)) | ELISA, FuncS | Rabbit scFv |
HPAB-0098-YC-S(P) | Rabbit Anti-KDR Recombinant Antibody; scFv Fragment (HPAB-0098-YC-S(P)) | ELISA, FuncS | Rabbit scFv |
HPAB-0502-YJ-S(P) | Human Anti-KDR Recombinant Antibody (clone 1); scFv Fragment | ELISA, FC | Human scFv |
HPAB-0503-YJ-S(P) | Human Anti-KDR Recombinant Antibody (clone 6); scFv Fragment | ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-326CQ | Rat Anti-Kdr Recombinant Antibody (TAB-326CQ) | ELISA, IHC | Rat IgG |
TAB-331CQ | Anti-Human KDR Recombinant Antibody (6.64) | IHC, ELISA | Mouse IgG1 |
TAB-326CQ-S(P) | Rat Anti-Kdr Recombinant Antibody; scFv Fragment (TAB-326CQ-S(P)) | ELISA, FC, WB | Rat scFv |
TAB-331CQ-S(P) | Anti-Human KDR Recombinant Antibody scFv Fragment (6.64) | ELISA, FC, IHC | |
TAB-332CQ-S(P) | Anti-Human KDR Recombinant Antibody scFv Fragment (4.13) | ELISA, FC, IHC |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-322CQ-S(P) | Anti-Human KDR Recombinant Antibody scFv Fragment (AK404R) | ELISA, WB | Human antibody |
TAB-325CQ-S(P) | Human Anti-KDR Recombinant Antibody; scFv Fragment (TAB-325CQ-S(P)) | ELISA, FC | Human scFv |
TAB-329CQ-S(P) | Human Anti-KDR Recombinant Antibody; scFv Fragment (TAB-329CQ-S(P)) | ELISA, WB, Neut | Human scFv |
TAB-330CQ-S(P) | Mouse Anti-KDR Recombinant Antibody; scFv Fragment (TAB-330CQ-S(P)) | ELISA, WB, Neut | Mouse scFv |
TAB-333CQ-S(P) | Human Anti-KDR Recombinant Antibody; scFv Fragment (TAB-333CQ-S(P)) | ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0624MZ | Chicken Anti-VEGFR-2 Polyclonal IgY | IHC, WB | Chicken antibody |
BRD-0709MZ | Chicken Anti-KDR Polyclonal IgY | WB | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1619CQ | Recombinant Mouse Anti-KDR Antibody (23B31) | WB, IP, FC, Neut | |
NEUT-1620CQ | Recombinant Rat Anti-Kdr Antibody (CBL840) | ELISA(Cap), Neut | IgG2a |
NEUT-1621CQ | Recombinant Rat Anti-Kdr Antibody (CBL880) | Neut, WB | IgG2 |
NEUT-1622CQ | Recombinant Mouse Anti-KDR Antibody (6B11) | WB, Neut | IgG1 |
NEUT-1623CQ | Recombinant Mouse Anti-KDR Antibody (CBL505) | FC, CyTOF, Neut | IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1927 | Hi-Affi™ Recombinant Rabbit Anti-KDR Monoclonal Antibody (DS1927AB) | IHC-P | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0097-YC-F(E) | Rabbit Anti-KDR Recombinant Antibody; Fab Fragment (HPAB-0097-YC-F(E)) | ELISA, FuncS | Rabbit Fab |
HPAB-0098-YC-F(E) | Rabbit Anti-KDR Recombinant Antibody; Fab Fragment (HPAB-0098-YC-F(E)) | ELISA, FuncS | Rabbit Fab |
HPAB-0099-YC-F(E) | Rabbit Anti-KDR Recombinant Antibody; Fab Fragment (HPAB-0099-YC-F(E)) | ELISA, FuncS | Rabbit Fab |
HPAB-M0126-YC-F(E) | Human Anti-KDR Recombinant Antibody (clone RD); Fab Fragment | ELISA | Human Fab |
HPAB-M0127-YC-F(E) | Human Anti-KDR Recombinant Antibody (clone PCABHL3); Fab Fragment | ELISA, Inhib | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-1580-CN | Recombinant Rabbit Anti-KDR Monoclonal Antibody (SU03-42) | WB, IF, IHC, IP | Rabbit IgG |
HPAB-0251-FY | Human Anti-KDR Recombinant Antibody (clone 043HAb-1) | ELISA | Human IgG1 |
HPAB-0252-FY | Human Anti-KDR Recombinant Antibody (clone 043HAb-2) | ELISA | Human IgG1 |
HPAB-0253-FY | Human Anti-KDR Recombinant Antibody (clone 043HAb-3) | ELISA | Human IgG1 |
HPAB-0254-FY | Human Anti-KDR Recombinant Antibody (clone 043HAb-4) | ELISA | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-079 | Afuco™ Anti-KDR ADCC Recombinant Antibody (Ramucirumab), ADCC Enhanced | IP, IF, FuncS, FC, Neut, ELISA | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0298-YJ-VHH | Recombinant Human Anti-KDR Nano Antibody (NTV1) | Inhib | Human VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
MHC-YF304 | A*24:02/Human VEGFR (SYGVLLWEI) MHC Monomer | MHC Multimer | |
MHC-YF772 | H-2Db/Human VEGFR2/KDR fragment 1 (FSNSTNDILI) MHC Pentamer | FCM |
There are currently no Customer reviews or questions for TAB-322CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.